An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

The delays in Alzheimer’s research is one example of how millions of dollars in research have been stalled as NIH grapples ...

New drug could reduce risk of early-onset Alzheimer’s disease - The results boost hopes similar treatments being developed to ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Researchers followed a small group of 22 patients who had genetic mutations that cause the overproduction of amyloid in the ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

The people involved in the study have rare genetic mutations, making it nearly certain they will develop Alzheimer's. AP reports on how mass firings and funding restrictions at the NIH are affecting ...

The world’s happiest country has been announced and for the eighth year in a row … it’s Finland! Researchers credited the country’s strong social support systems, high trust ...

A new study shows people who take an Amyloid lowering drug, delayed onset of the illness. The study is small with just a few dozen participants but it is long term and looked at those participants ...